CN1380415A - Synthesis of related gene for producing carotenoid in transgenic plant - Google Patents
Synthesis of related gene for producing carotenoid in transgenic plant Download PDFInfo
- Publication number
- CN1380415A CN1380415A CN 01105878 CN01105878A CN1380415A CN 1380415 A CN1380415 A CN 1380415A CN 01105878 CN01105878 CN 01105878 CN 01105878 A CN01105878 A CN 01105878A CN 1380415 A CN1380415 A CN 1380415A
- Authority
- CN
- China
- Prior art keywords
- gene
- synthetic
- gac
- gtc
- astaxanthin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 97
- 235000021466 carotenoid Nutrition 0.000 title abstract description 29
- 150000001747 carotenoids Chemical class 0.000 title abstract description 29
- 230000009261 transgenic effect Effects 0.000 title abstract description 3
- 230000015572 biosynthetic process Effects 0.000 title description 5
- 238000003786 synthesis reaction Methods 0.000 title description 5
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 42
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 40
- 239000001168 astaxanthin Substances 0.000 claims abstract description 40
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 40
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 40
- 108700005078 Synthetic Genes Proteins 0.000 claims abstract description 13
- 101150028535 CRTZ gene Proteins 0.000 claims abstract description 9
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 9
- 101100114901 Streptomyces griseus crtI gene Proteins 0.000 claims abstract description 8
- 101150000046 crtE gene Proteins 0.000 claims abstract description 8
- 101150085103 crtY gene Proteins 0.000 claims abstract description 8
- 101100168661 Paracoccus sp. (strain N81106 / MBIC 01143) crtW gene Proteins 0.000 claims abstract description 7
- 101150081158 crtB gene Proteins 0.000 claims abstract description 7
- 101100061456 Streptomyces griseus crtB gene Proteins 0.000 claims abstract description 6
- 101150011633 crtI gene Proteins 0.000 claims abstract description 6
- 239000002773 nucleotide Substances 0.000 claims description 25
- 125000003729 nucleotide group Chemical group 0.000 claims description 25
- 241000894006 Bacteria Species 0.000 claims description 14
- 230000000968 intestinal effect Effects 0.000 claims description 9
- 108020004705 Codon Proteins 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 108091008146 restriction endonucleases Proteins 0.000 claims description 8
- 108020005038 Terminator Codon Proteins 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241001478240 Coccus Species 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 6
- 108090000364 Ligases Proteins 0.000 claims description 4
- 235000011180 diphosphates Nutrition 0.000 claims description 4
- 108060004506 lycopene beta-cyclase Proteins 0.000 claims description 4
- 108010001545 phytoene dehydrogenase Proteins 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 101710173432 Phytoene synthase Proteins 0.000 claims description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims 5
- 108091028664 Ribonucleotide Proteins 0.000 claims 1
- 238000012239 gene modification Methods 0.000 claims 1
- 230000005017 genetic modification Effects 0.000 claims 1
- 235000013617 genetically modified food Nutrition 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 239000002336 ribonucleotide Substances 0.000 claims 1
- 125000002652 ribonucleotide group Chemical group 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 14
- 238000012408 PCR amplification Methods 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- 235000013311 vegetables Nutrition 0.000 abstract description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 1
- 150000001746 carotenes Chemical class 0.000 abstract 1
- 235000005473 carotenes Nutrition 0.000 abstract 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 20
- 238000013461 design Methods 0.000 description 12
- 239000012634 fragment Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 7
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 6
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 2
- 101150039504 6 gene Proteins 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 235000008537 Brassica juncea var. integrifolia Nutrition 0.000 description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 241001674939 Caulanthus Species 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 150000001514 astaxanthins Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 244000117494 takana Species 0.000 description 2
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- 101100225042 Arabidopsis thaliana ECI3 gene Proteins 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010066605 Geranylgeranyl-Diphosphate Geranylgeranyltransferase Proteins 0.000 description 1
- 102100030500 Heparin cofactor 2 Human genes 0.000 description 1
- 101001082432 Homo sapiens Heparin cofactor 2 Proteins 0.000 description 1
- 101000843810 Homo sapiens Hydroxycarboxylic acid receptor 1 Proteins 0.000 description 1
- 101001035752 Homo sapiens Hydroxycarboxylic acid receptor 3 Proteins 0.000 description 1
- 101001057133 Homo sapiens Melanoma-associated antigen E2 Proteins 0.000 description 1
- 101000963221 Homo sapiens mRNA guanylyltransferase Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 102100027260 Melanoma-associated antigen E1 Human genes 0.000 description 1
- 102100027255 Melanoma-associated antigen E2 Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241001234610 Rapistrum rugosum Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- -1 astaxanthin Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 108010080924 beta-carotene ketolase Proteins 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 102100039604 mRNA guanylyltransferase Human genes 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a related gene for proudcing carotenoid in transgenic plant. Said invention utilizes overlapping extension PCR amplification process and uses six genes of crtE, crtB, crtI, crtW, crtY and crtZ as template to synthesize the related gene for synthesizing astaxanthin with plant preference code and can make synthetic gene express in plant to produce the carotene substances of astaxanthin etc. so as to improve quality of grain crops and vegetable.
Description
The present invention relates to the plant bioreactor in the plant genetic engineering field, more specifically say so by synthetic 6 genes involveds can in plant materials, producing carotenoid of the method for chemosynthesis.
Carotenoid is important natural pigment, extensively exists in the animal and plant body, and from having more than 600 kind of carotenoid to be found so far, its color is extremely orange red from yellow, the color that is used for modifying food for a long time.Along with the understanding to the carotenoid chemical structure, the function of carotenoid is excavated gradually.
Carotenoid has anti-oxidant function.9-11 conjugated double bond arranged in the carotenoid chemical structure, can with combined with radical.Cause cell senescence even death after avoiding the oxidative damage of cell to be accumulated to a certain degree.Carotenoid has anticancer change effect.In the influences of carotenoid to aflatoxin initiation liver cancer such as research astaxanthin, find that carotenoid can reduce the number and the size of liver lesion.Carotenoid has the enhancing body immunization.Carotenoid such as astaxanthin can stimulate production of antibodies (Liu Ziyi, 1997, Chinese marine drug).
The discovery of the numerous functions of carotenoid has increased on the market demand to this compounds greatly.Only astaxanthin is a kind of, and annual value of demand promptly surpasses 100,000,000 dollars (Liang Shizhong, 2000, food and fermentation industries).Present most of carotinoid compounds is to obtain by chemosynthesis, needs very high cost and resource (Johnson EA, 1995, Adv Biochem Eng Biotechnol).Cultivate Du Shi salt tolerant algae biology by big area and also can obtain a large amount of carotenoid, but this algae can only be in the breed of the area of arid, to the requirement of water quality, environment and light very high (Zheng Xiaodong, 2000, journal of Zhejiang university).Carotinoid compounds such as astaxanthin can also directly extract from first section class animal, but content is very low, are not suitable for mass production (Chinese feedstuff industry Information Network).Utilize carotinoid compounds such as microorganisms producing astaxanthin to become the emphasis of recent researches, wherein at most with red Fife's yeast research, this bacterium has some essential feature as the pigment biogenetic derivation: quick different oxygen metabolism, incubation time is short, can realize high density fermentation in fermentor tank.Though this quasi-microorganism has very big potentiality to be exploited, the defective that present ubiquity yields poorly also fails to commercially produce on a large scale (Wang Jufang, 2000, biotechnology progress).
Utilize genetic engineering technique, key gene clone and transformation with carotenoid such as synthesizing astaxanthins, utilize suitable promotor to regulate and control, these genes are transformed in bacterium, yeast and the plant simultaneously, realize efficiently expressing of carotinoid compounds such as astaxanthin, will satisfy the market that develops rapidly great demand these products.Wherein have more social value and marketable value with the plant of cultivating energy mass production β-Hu Luobusu and astaxanthin.As the golden paddy rice of material produce, golden wild cabbage and golden rape, will become the scenery of human health with crops such as paddy rice, wild cabbage and rapes.
Begin synthetic β-Hu Luobusu from glycolysis-product acetyl-CoA and need a series of enzyme catalysiss.Most of biologies will be through acetyl-CoA to farnesyl pyrophosphate (FPP) stage, and FPP synthesizes ergosterol or β-Hu Luobusu under different enzyme effects.From FPP to the β-Hu Luobusu, need four kinds of enzymes to participate in.Farnesyl pyrophosphate (FPP) is synthetic ridge ox base ridge ox base tetra-sodium (GGPP) under the catalysis of ridge ox base ridge ox base pyrophosphate synthetase (CrtE), GGPP produces phytoene under phytoene synthetase (CrtB) effect, under phytoene desaturase (CrtI) effect, form Lyeopene gradually afterwards, under lycopene beta cyclase (CrtY) catalysis, Lyeopene synthesizes β-Hu Luobusu at last.Astaxanthin is a β-Hu Luobusu synthetic terminating point, changes astaxanthin into by β-Hu Luobusu and need add two ketone groups and hydroxyl, external synthetic relatively difficulty.Can be under the catalysis of two enzymes but only need in vivo by the β-Hu Luobusu synthesizing astaxanthin.β-Hu Luobusu hydroxylase (CrtZ) and β-Hu Luobusu ketolase (CrtW) can add hydroxyl and ketone group on the C3 of β-Hu Luobusu C3 ' and C4 C4 ' position, form astaxanthin (Claudia SD, 2000, EnviromentalBiotechnology).
To so far, from bacterium, plant, algae and fungi, cloned nearly 150 respectively and synthesized relevant gene (Hirschberg J, 1997, Purelity Applied Chemical) with carotenoid.The gene that these functions are close is widely different on nucleotide level.On the one hand, these genes can be transformed in the different microorganism or plant according to function combinations together, produce various carotenoid products (Misawa N, 1998, Applied and Environmental Microbiology).On the other hand, the difference of gene provides assurance for plant production carotenoid product, the conversion of foreign gene can not change the function of congenerous gene in the plant, cause the gene silencing phenomenon, can strengthen the function of similar gene on the contrary, improve the output (Hirschberg J, 2000, Nature Biotechnology) of product.
The present invention is template (ncbi.nlm.nih.gov:80) with the amino acid of secondary coccus (Pracoccus marcusii) 6 kinds of relevant enzymes in astaxanthin is synthetic, according to the plant-preference password, and these genes of chemosynthesis.These 6 genes are respectively ridge ox base ridge ox base pyrophosphate synthetase gene (crtE); Phytoene synthase gene (crtB); Phytoene desaturase gene (crtI); Lycopene beta cyclase gene (crtY); β-Hu Luobusu '-hydroxylase gene (crtZ) and β-Hu Luobusu ketolase gene (crtW).
Most of carotenoid synthase genes (crt) clone and expression in intestinal bacteria once, but carotenoid output is extremely low in the intestinal bacteria (every gram dry cell weight only has the 10-500 microgram); With carotenoid synthase gene transformation yeast, can obtain higher output (every gram dry cell weight contains 0.4 milligram), be equivalent to the content astaxanthin (Johnson EA, 1995, Adv BiochemEng Biotechnol) that produces in red Fife's yeast.Yet most of yeast are easy to carry out an other pathways metabolism in the carotenoid building-up process, produce ergosterol, thereby the output of carotenoid is lowered (BalleyJE, 1991, Science).Utilize carotenoid materials such as plant production astaxanthin to have lot of advantages: (1) cost is low; (2) safety; (3) stable, can be hereditary, express the offspring.
Just because of have extremely tempting development prospect with plant production carotenoid, a lot of in the world laboratories are in the research work of carrying out this respect, and in tobacco, tomato, paddy rice, successfully synthesized the β-Hu Luobusu material, make the output of β-Hu Luobusu increase substantially raising (NormileD, 2000, Science).These research work have convincingly demonstrated plant has huge development potentiality in the exploitation carotinoid compounds.In order to improve the output of this compounds, we according to the plant-preference encryption design 6 genes of synthesizing astaxanthin.
The domestic report that does not also utilize gene engineering method to produce astaxanthin so far, once in food-yeast (Candida utilis), utilized above-mentioned 6 genes produce astaxanthins achieving success (MisawaN abroad, 1998, Applied and Environmental Microbiology), synthesizing astaxanthin also has successfully report in plant, but the intermediate product in the building-up process is the β-Hu Luobusu that plant self produces, because the content of β-Hu Luobusu in plant is very low, the also very low (BramleyPM of the content of astaxanthin, 2000, Nature Biotechnology).
The objective of the invention is to utilize overlapping extension PCR amplification technique is template with crtE, crtB, crtI, crtY, six genes of crtZ, crtW, synthetic astaxanthin synthesis related gene with plant-preference password.
Another object of the present invention is that the synthetic gene is expressed in plant, produces carotenoid materials such as astaxanthin.
A further object of the present invention is to utilize the synthetic gene to improve the quality of food crop and vegetables, helps the healthy protective foods of people with preparation.
The present invention adopts following method to implement the present invention:
Redesign the nucleotide sequence of beta carotene ketolase gene (CrtW) and lycopene beta cyclase gene (crtY) in the secondary coccus according to the plant-preference password, and form associating gene C rtWcrtY.
The overlapping extension PCR method of synthetic employing of CrtWcrtY gene carries out pcr amplification in conjunction with the high temperature resistant polysaccharase of high-fidelity.Nucleotide sequence is cloned and measured to gene in intestinal bacteria, be 1997bp Nucleotide from codon ATG to termination codon TAA length.Insert the preceding paragraph in 726~786 positions of gene and cut sequence automatically:
CAACTCCTCAACTTCGACCTCCTCAAACTCGCA
GGCGACGTCGAATCCAACCCAGGCCCA。
The Nucleotide and the aminoacid sequence of complete synthesis crtWcrtY gene are as follows:
ATGTCCGCACACGCACTCCCAAAAGCAGACCTCACCGCAACCTCCCTCATCGTCTCCGGTGGTATCATCGCA--?72
M S A H A L P K A D L T A T S L I V S G G I I A
GCATGGCTCGCACTCCACGTCCACGCACTCTGGTTCCTCGACGCAGCAGCACACCCAATCCTCGCAGTCGCA--144
A W L A L H V H A L W F L D A A A H P I L A V A
AACTTCCTCGGTCTCACCTGGCTCTCCGTCGGTCTCTTCATCATCGCACACGACGCAATGCACGGTTCCGTC--216
N F L G L T W L S V G L F I I A H D A M H G S V
GTCCCAGGTAGACCAAGAGCAAACGCAGCAATGGGTCAACTCGTCCTCTGGCTCTACGCAGGTTTCTCCTGG--288
V P G R P R A N A A M G Q L V L W L Y A G F S W
AGAAAGATGATCGTCAAGCACATGGCACACCACAGACACGCAGGTACTGACGACGACCCAGACTTCGACCAC--360
R K M I V K H M A H H R H A G T D D D P D F D H
GGTGGTCCAGTCAGATGGTACGCAAGATTCATCGGTACTTACTTCGGTTGGAGAGAAGGTCTCCTCCTCCCA--432
G G P V R W Y A R F I G T Y F G W R E G L L L P
GTCATCGTCACCGTCTACGCACTCATCCTCGGTGACAGATGGATGTACGTCGTCTTCTGGCCACTCCCATCC--504
V I V T V Y A L I L G D R W M Y V V F W P L P S
ATCCTCGCATCCATCCAACTCTTCGTCTTCGGCACCTGGCTCCCACACAGACCAGGTCACGACGCATTCCCA--576
I L A S I Q L F V F G T W L P H R P G H D A F P
GACAGACACAACGCAAGATCCTCCAGAATCTCCGACCCAGTCTCCCTCCTCACCTGCTTCCACTTCGGTGGC--648
D R H N A R S S R I S D P V S L L T C F H F G G
TACCACCACGAACACCACCTCCACCCAACCGTCCCTTGGTGGAGACTCCCATCCACCAGAACCAAAGGCGAC--720
Y H H E H H L H P T V P W W R L P S T R T K G D
ACCGCACAACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGAATCCAACCCAGGCCCAATGACC--792
T A Q L L N F D L L K L A G D V E S N P G P M T
CACGACGTCCTCCTCGCAGGTGCAGGTCTCGCAAACGGTCTCATCGCACTCGCACTCAGAGCAGCAAGACCA--864
H D V L L A G A G L A N G L I A L A L R A A R P
GACCTCAGAGTCCTCCTCCTCGACCACGCAGCAGGTCCATCCGAAGGTCACACCTGGTCCTGCCACGACCCA--936
D L R V L L L D H A A G P S E G H T W S C H D P
GACCTCTCCCCACACTGGCTCGCAAGACTCAAGCCACTCAGAAGAGCAAACTGGCCAGACCAAGAAGTCAGA-1008
D L S P H W L A R L K P L R R A N W P D Q E V R
TTCCCAAGACACGCAAGAAGACTCGCAACCGGCTACGGCTCCCTCGACGGTGCAGCACTCGCAGACGCAGTC-1080
F P R H A R R L A T G Y G S L D G A A L A D A V
GTCAGATCCGGTGCAGAAATCAGATGGGACTCCGACATCGCACTCCTCGACGCACAAGGTGCAACCCTCTCC-1152
V R S G A E I R W D S D I A L L D A Q G A T L S
TGCGGTACTAGAATCGAAGCAGGCTCCGTCCTCGACGGCAGAGGCCCACACCCATCCAGACACCTCACCCTC-1224
C G T R I E A G S V L D G R G P H P S R H L T L
GGCTTCCACAAGTTCCTCGGTGTCGAAATCGAAACCGACAGACCACACGGTGTCCCAAGACCAGTCATCATG-1296
G F H K F L G V E I E T D R P H G V P R P V I M
GACGGCACCGTCACCCAAAGAGACGGCTACGGCTTCATCTACCTCCTCCCATTCTCCAGAACCAGAATCCTC-1368
D G T V T Q R D G Y G F I Y L L P F S R T R I L
ATCGAAGACACCAGATACTCCGACGGCGGCGACCTCGACGACGACGCACTCGCAGCAGCATCCCAAGACTAC-1440
I E D T R Y S D G G D L D D D A L A A A S Q D Y
GCAAGACAACAAGGCTGGACCGGTGCAGAAGTCAGAAGAGAAAGAGGCATCCTCCCAATCGCACTCGCACAC-1512
A R Q Q G W T G A E V R R E R G I L P I A L A H
GACGCAGCAGGTTTCTGGGCAGACCACGCAGAAGGTCCAGTCCCAGTCGGTCTCAGAGCAGGCTTCTTCCAC-1584
D A A G F W A D H A E G P V P V G L R A G F F H
CCAGTCACCGGCTACTCCCTCCCATACGCAGCACAAGTCGCAGACGTCGTCGCAGGTCTCTCCGGTCCACCA-1556
P V T G Y S L P Y A A Q V A D V V A G L S G P P
GGCACCGACGCACTCAGAGGTGCAATCAGAGACTACGCAATCGACAGAGCAAGAAGAGACAGATTCCTCAGA-1728
G T D A L R G A I R D Y A I D R A R R D R F L R
CTCCTCAACAGAATGCTCTTCAGAGGCTGCGCACCAGACAGAAGATACACCCTCCTCCAAAGACTCTACAGA-1800
L L N R M L F R G C A P D R R Y T L L Q R L Y R
ATGCCACACGGTCTCATCGAAAGATTCTACGCAGGTAGACTCTCCGTCGCAGACCAACTCAGAATCGTCACC-1872
M P H G L I E R F Y A G R L S V A D Q L R I V T
GGCAAGCCACCAATCCCACTCGGCACCGCAATCAGATGCCTCCCAGAAAGACCACTCCTCAAGGAAAACGCA-1994
G K P P I P L G T A I R C L P E R P L L K E N A
Redesign phytoene desaturase gene (crtZ) and beta carotene '-hydroxylase gene (crtZ) in the secondary coccus according to the plant-preference password) nucleotide sequence, and be combined into associating gene C rtIcrtZ.
The overlapping extension PCR method of synthetic employing of CrtIcrtZ gene carries out pcr amplification in conjunction with the high temperature resistant polysaccharase of high-fidelity.Nucleotide sequence is cloned and measured to gene in intestinal bacteria, be 2034bp Nucleotide from codon ATG to termination codon TAA length.Insert the preceding paragraph in 1485~1545 positions of gene and cut sequence automatically:
CAACTCCTCAACTTCGACCTCCTCAAACTCGCA
GGCGACGTCGAATCCAACCCAGGCCCA。
The Nucleotide and the aminoacid sequence of complete synthesis crtIcrtZ gene are as follows:
ATGAACGCACACTCCCCAGCAGCAAAGACCGCAATCGTCATCGGTGCAGGTTTCGGTGGTCTCGCACTCGCA--?72
M N A H S P A A K T A I V I G A G F G G L A L A
ATCAGACTCCAATCCGCAGGCATCGCAACCACCCTCGTCGAGGCAAGAGACAAGCCAGGCGGTAGAGCATAC--144
I R L Q S A G I A T T L V E A R D K P G G R A Y
GTCTGGCACGACCAAGGCCACGTCTTCGACGCAGGTCCAACCGTCATCACCGACCCAGACGCACTCAAGGAA--216
V W H D Q G H V F D A G P T V I T D P D A L K ECTCTGGGCACTCACCGGTCAAGACATGGCAAGAGACGTCACCCTCATGCCAGTCTCCCCATTCTACAGACTC--288?L W A L T G Q D?M A R D V T L M P V S P F Y R LATGTGGCCAGGTGGCAAGGTCTTCGACTACGTCAACGAGGCAGACCAACTCGAAAGACAAATCGCACAATTC--360?M W P G G K V F D Y V N E A D Q L E R Q I A Q FAACCCAGACGACCTCGAAGGTTACAGAAGATTCAGAGACTACGCAGAGGAGGTCTACCAGGAGGGCTACGTC--432?N P D D L E G Y R R F R D Y A E E V Y Q E G Y VAAACTCGGCACCGTCCCATTCCTCAAGCTCGGTCAAATGCTCAAGGCAGCACCAGCACTCATGAAACTCGAA--504?K L G T V P F L K L G Q M L K A A P A L M K L EGCATACAACTCCGTCCACGCAAAGGTCGCAACCTTCATCAAGGACCCATACCTCAGACAGGCATTCTCCTAC--576?A Y N S V H A K V A T F I K D P Y L R Q A F S YCACACCCTCCTCGTCGGTGGTAATCCATTCTCCACCTCCTCCATCTACGCACTCATCCACGCACTCGAAAGA--648?H T L L V G G N P F S T S S I Y A L I H A L E RAGAGGTGGTGTCTGGTTCGCAAAGGGTGGCACCAACCAGCTCGTCGCAGGTATGGTCGCACTCTTCGAGAGA--720?R G G V W F A K G G T N Q L V A G M V A L F E RCCAGGTGGTCAAATGATGCTCAACGCAAAGGTCGCAAGAATCGAAACCGAGGGTGCAAGAACCACCGGTGTC--792?P G G Q M M L N A K V A R I E T E G A R T T G VACCCTCGCAGACGGTAGATCCCTCAGAGCAGACATGGTCGCATCCAACGGTGACGTCATGCACAACTACAGA--864?T L A D G R S L R A D M V A S N G D V M H N Y RGACCTCCTCGGTCACACCGCAAGAGGTCAATCCAGAGCAAAGTCCCTCGACAGAAAGAGATGGTCCATGTCC--936?D L L G H T A R G Q S R A K S L D R K R W S M SCTCTTCGTCCTCCACTTCGGTCTCAGAGAAGCACCAAAGGACATCGCACACCACACCATCCTCTTCGGTCCA-1008?L F V L H F G L R E A P K D I A H H T I L F G PAGATACAAGGAACTCGTCAACGAAATCTTCAAGGGTCCAAAACTCGCAGAGGACTTCTCCCTCTACCTCCAC-1080?R Y K E L V N E I F K G P K L A E D F S L Y L HTCCCCATGCACCACCGACCCAGACATGGCACCACCAGGCATGTCCACCCACTACGTCCTCGCACCAGTCCCA-1152?S P C T T D P D M A P P G M S T H Y V L A P V PCACCTCTCCAGAGCAGAAATCGACTGGGCAGTCGAAGGCCCAAGATACGCAGACAGAATCCTCGCATTCCTC-1224?H L S R A E I D W A V E G P R Y A D R I L A F LGAAGAAAGACTCATCCCAAACCTCAGAGCAAACCTCACCAGAACCAGAATCTTCACCCCAGCAGACTTCGCA-1296?E E R L I P N L R A N L T R T R I F T P A D F ATCCGAACTCAACGCACACCACGGCTCCGCATTCTCCGTCGAACCAATCCTCACCCAATCCGCATGGTTCAGA-1368?S E L N A H H G S A F S V E P I L T Q S A W F RCCACACAACAGAGACAAGACCATCAGAAACTTCTACCTCGTCGGTGCAGGTACTCACCCAGGTGCAGGTATC-1440?P H N R D K T I R N F Y L V G A G T H P G A G ICCAGGTGTCGTCGGTTCCGCAAAGGCAACCGCACAAGTCATGCTCCAACTCCTCAACTTCGACCTCCTCAAA-1512?P G V V G S A K A T A Q V M L Q L L N F D L L KCTCGCAGGCGACGTCGAATCCAACCCAGGCCCAATGACCAACTTCCTCATCGTCGTCGCAACCGTCCTCGTC-1584?L A G D V E S N P G P M T N F L I V V A T V L VATGGAACTCACCGCATACTCCGTCCACAGATGGATCATGCACGGTCCACTCGGCTGGGGCTGGCACAAATCC-1656?M E L T A Y S V H R W I M H G P L G W G W H K SCACCACGAAGAACACGACCACGCACTCGAAAAAAACGACCTCTACGGTCTCGTCTTCGCAGTCATCGCAACC-1728?H H E E H D H A L E K N D L Y G L V F A V I A TGTCCTCTTCACCGTCGGTTGGATCTGGGCACCAGTCCTCTGGTGGATCGCACTCGGTATGACCGTCTACGGT-1800?V L F T V G W I W A P V L W W I A L G M T V Y GCTCATCTACTTCGTCCTCCACGACGGTGTCGTCCACCAAAGATGGCCATTCAGATACATCCCAAGAAAGGGC-1872
L I Y F V L H D G V V H Q R W P F R Y I P R K G
TACGCAAGAAGACTCTACCAAGCACACAGACTCCACCACGCAGTCGAAGGCAGAGACCACTGCGTCTCCTTC-1944
Y A R R L Y Q A H R L H H A V E G R D H C V S F
GGCTTCATCTACGCACCACCAGTCGATAAACTCAAAGAAGACCTCAAGACCTCCGGCGTCCTCAGAGCAGAA-2016
G F I Y A P P V D K L K E D L K T S G V L R A E
GCAGAAGAAAGAACCTAA-2034
A E E R T
Redesign the nucleotide sequence of phytoene synthase gene in the secondary coccus (crtB) and ridge ox base ridge base pyrophosphate synthetase gene (crtE) according to the plant-preference password, and form associating gene crtBcrtE.
The overlapping extension PCR method of synthetic employing of crtBcrtE gene carries out pcr amplification in conjunction with the high temperature resistant polysaccharase of high-fidelity.Nucleotide sequence is cloned and measured to gene in intestinal bacteria, be 1848bp Nucleotide from codon ATG to termination codon TAA length.Insert the preceding paragraph in 912~972 positions of gene and cut sequence automatically: CAACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGAATCCAACCCAGG CCCA.
The Nucleotide and the aminoacid sequence of complete synthesis crtBcrtE gene are as follows:
ATGTCCGACCTCGTCCTCACCTCCACCGAGGCCATCACCCAGGGCTCCCAATCCTTCGCCACCGCAGCCAAA--?72
M S D L V L T S T E A I T Q G S Q S F A T A A K
CTCATGCCACCAGGCATCAGAGACGACACCGTCATGCTCTACGCCTGGTGCAGACACGCAGACGACGTCATC--144
L M P P G I R D D T V M L Y A W C R H A D D V I
GACGGTCAGGCACTCGGCTCCAGACCAGAGGCAGTCAACGACCCACAGGCCAGACTCGACGGTCTCAGAGCC--216
D G Q A L G S R P E A V N D P Q A R L D G L R A
GACACCCTCGCAGCACTCCAGGGTGACGGTCCAGTCACTCCACCATTCGCAGCACTCAGAGCAGTCGCAAGA--288
D T L A A L Q G D G P V T P P F A A L R A V A R
AGACACGACTTCCCACAGGCATGGCCAATGGACCTCATCGAGGGCTTCGCAATCGACGTTGAGGCAAGAGAC--360
R H D F P Q A W P M D L I E G F A I D V E A R D
TACAGAACCCTCGACGACGTCCTCGAATACTCCTACCACGTCGCAGGCATCCTCGGTGTCATGATGGCCAGA--432
Y R T L D D V L E Y S Y H V A G I L G V M M A R
GTCATGGGTGTCAGAGACCACCCAGTCCTCGACAGAGCCTGCGACCTCGGTCTCGCCTTCCAGCTCACCCAC--504
V M G V R D H P V L D R A C D L G L A F Q L T H
ATCGCAAGAGACGTCATCGACTACGCAAGAATCGGCAGATGCTACCTCCCAGGCGACTGGCTCGACCACGCA--576
I A R D V I D Y A R I G R C Y L P G D W L D H A
GGCGCAAGAGTCGATGGTCCAGTCCCATCCCCAGAACTCTACACCGTCATCCTCAGACTCCTCGACGCAGCA--648
G A R V D G P V P S P E L Y T V I L R L L D A A
GAGCCATACTACCCATCCGCAAGAGTCGGTCTCGCAGACCTCCCACCAAGATGCGCATGGTCCATCCCAGCA--720
E P Y Y P S A R V G L A D L P P R C A W S I P A
GCATTCAGAATCTACAGAGCAATCGGTCTCCCAATCAGAAAGGGTGGTCCAGAGGCATACAGACAAAGAATC--792
A F R I Y R A I G L P I R K G G P E A Y R Q R I
TCCACCTCCAAGGCAGCAAAGATCGGTCTCCTCGGCATCGGTGGTTGGGACGTCGCAGACCACGCTTGCAGA--864
S T S K A A K I G L L G I G G W D V A D H A C R
GGCTCCGGTGTCTCCAGACAAGACCTCTGGACCAGACCACACCACGCACAACTCCTCAACTTCGACCTCCTC--936
G S G V S R Q D L W T R P H H A Q L L N F D L L
AAACTCGCAGGCGACGTCGAATCCAACCCAGGCCCAATGAGAAGAGACGTCAACCCAATCCACGCAACCCTC--1008
K L A G D V E S N P G P M R R D V N P I H A T L
CTCCAAACCAGAATCGAAGAAATCGCACAAGGCTTCGGTGCAGTCCTCCAACCACTCGGTGCAGCAATGGCA--1080
L Q T R I E E I A Q G F G A V L Q P L G A A M A
GCACTCTCCTCCGGTAAGAGATTCAGAGGTATGCTCATGCTCCTCGCAGCAGAAGCATCCGGTGGTGTCTGC--1152
A L S S G K R F R G M L M L L A A E A S G G V C
GACACCATCGTCGATGCAGCCTGCGCAGTCGAAATGGTCCACGCAGCATCCCTCATCTTCGACGACCTCCCA--1224
D T I V D A A C A V E M V H A A S L I F D D L P
TGTATGGACGACGCAGGTCTCAGAAGAGGTCAACCAGCAACCCACGTCGCACACGGTGAATCCAGAGCAGTC--1296
C M D D A G L R R G Q P A T H V A H G E S R A V
CTCGGTGGCATCGCACTCATCACCGAAGCAATGGCACTCCTCGCAGGTGCAAGAGGTGCATCCGGTACTGTC--1368
L G G I A L I T E A M A L L A G A R G A S G T V
AGAGCACAACTCGTCAGAATCCTCTCCAGATCCCTCGGTCCACAAGGTCTCTGCGCAGGTCAAGACCTCGAC--1440
R A Q L V R I L S R S L G P Q G L C A G Q D L D
CTCCACGCAGCAAAGAACGGTGCAGGTGTCGAACAAGAACAAGACCTCAAAACCGGTGTCCTCTTCATCGCA--1512
L H A A K N G A G V E Q E Q D L K T G V L F I A
GGTCTCGAAATGCTCGCAGTCATCAAAGAGTTCGACGCAGAAGAACAAACCCAAATGATCGACTTCGGTAGA--1584
G L E M L A V I K E F D A E E Q T Q M I D F G R
CAACTCGGTAGAGTCTTCCAATCCTACGACGACCTCCTCGAAGTCGTCGGTGATCAAGCAGCACTCGGTAAA--1656
Q L G R V F Q S Y D D L L E V V G D Q A A L G K
GACACCGGTAGAGACGCAGCAGCACCAGGTCCAAGAAGAGGTCTCCTCGCAGTCTCCGACCTCCAAAAGGTC--1728
D T G R D A A A P G P R R G L L A V S D L Q K V
TCCAGACAATACGAAGCATCCAGAGCACAACTCGAAGGTATGGTCGGTTCCAAGAGACTCCAAGCACCAGAA--1800
S R Q Y E A S R A Q L E G M V G S K R L Q A P E
ATCGAAGCACTCCTCGAAAGAGTCCTCCCATACGCAGCAAGAGCATAA--1848
I E A L L E R V L P Y A A R A
The present invention utilizes advanced method for synthesizing gene, and 6 genes that synthesizing astaxanthin is necessary synthesize and clone by the method for amplification in vitro.The synthetic gene has the following advantages:
(1) with 6 gene crtW of astaxanthin synthetic in the secondary coccus, crtZ, crtY, crtI, crtB and crtE are genetic background, all adopt the plant-preference password, Nucleotide is transformed, noted simultaneously the inner conventional Nucleotide restriction endonuclease sites of gene is eliminated.
(2) 6 genes are combined in twos an associating gene, be crtWcrtY, crtIcrtZ, crtBcrtE adds the preceding paragraph in the junction of gene and gene and cuts sequence automatically: CAACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGAATCCAACCCAGG CCCA.When the associating gene is expressed in plant, be divided into two, produce two protein with complete function.The synthetic construction step that reduces Expression element of associating gene makes polygenic Plant Transformation become simple and easy to do.
(3) 6 genes of synthetic have very strong function, can produce astaxanthin in lacking the intestinal bacteria of these genes, the bacterium colony express red.
Description of drawings
The design of primers of Fig. 1 .crtWcrtY gene fragment 1 (initial to 1008 sites) from 5 ' ATG
Fig. 2 .crtWcrtY gene fragment 2 (from 1008 sites to 3 ' TAA termination 1997) design of primers.
The design of primers of Fig. 3 .crtIcrtZ gene fragment 1 (initial to 1080 sites) from 5 ' ATG.
The design of primers of Fig. 4 .crtIcrtZ gene fragment 2 (from 1080 sites to 3 ' TAA stop 2034).
The design of primers of Fig. 5 .crtBcrtE gene fragment 1 (initial to 936 sites) from 5 ' ATG.
The design of primers of Fig. 6 .crtBcrtE gene fragment 2 (from 936 sites to 3 ' TAA stop 1848).
The building-up process of Fig. 7 .crtWcrtY gene.Earlier synthetic 1008bp (1) and 990bp (3) band connect into 1997bp (2) by PCR with two fragments.
The building-up process of Fig. 8 .crtIcrtZ gene.Earlier synthetic 1080bp (1) and 954bp (4) band connect into 2034bp (3) by PCR with two fragments.
The building-up process of Fig. 9 .crtBcrtE gene.Earlier synthetic 936bp (3) and 912bp (4) band connect into 1848bp (1) by PCR with two fragments.
Figure 10. 6 gene crtIcrtZ of astaxanthin synthetic, crtBcrtE, crtWcrtY are at expression in escherichia coli, and red bacterium colony is for transforming the intestinal bacteria of these genes.
The chemosynthesis of embodiment 1 crtWcrtY gene
According to design oligonucleotides synthetic primer illustrated in figures 1 and 2, primer length is 60-90bp, and overlap is 20-30bp between two primers, and the Tm value is 64-80 ℃.Oligonucleolide primers synthesizes commercialization, and is synthetic by Shanghai biotechnology branch office.
Utilize high temperature-resisting DNA polymerase eXTaq (the Japanese TAKANA company) synthetic gene of high-fidelity, all primers are added laggard performing PCR amplification, middle primer consumption is 5-10ng, and both sides primer consumption is 100-200ng, and the pcr amplification condition is 94 ℃, 30s; 60-72 ℃, 30s; 72 ℃, 1-2min.Carry out 25-35 circulation altogether.
The crtWcrtY gene divides two sections to synthesize:
First section begins to 1008 from the gene codon ATG, designs 16 primers altogether.The nucleotide sequence of primer is:
HCE1:
GGT,CTC,CTC,CTC,CCA,GTC,ATC,GTC,ACC,GTC,TAC,GCA,CTC,ATC,CTC,
GGT,GAC,AGA,TGG,ATG,TAC,GTC,GTC,TTC,TGG,CCA,CTC,CCA,TCC,ATC
HCE3:
ACT,TCG,ACC,ACG,GTG,GTC,CAG,TCA,GAT,GGT,ACG,CAA,GAT,TCA,TCG,
GTA,CTT,ACT,TCG,GTT,GGA,GAG,AAG,GTC,TCC,TCC,TCC,CAG,TCA,TCG
HCE5:
TCT,CCT,GGA,GAA,AGA,TGA,TCG,TCA,AGC,ACA,TGG,CAC,ACC,ACA,GAC,
ACG,CAG,GTA,CTG,ACG,ACG,ACC,CAG,ACT,TCG,ACC,ACG,GTG,GTC,CAG
HCE7:
GTC,GTC,CCA,GGT,AGA,CCA,AGA,GCA,AAC,GCA,GCA,ATG,GGT,CAA,CTC,
GTC,CTC,TGG,CTC,TAC,GCA,GGT,TTC,TCC,TGG,AGA,AAG,ATG,ATC,GTC
HCE9:
ACT,TCC,TCG,GTC,TCA,CCT,GGC,TCT,CCG,TCG,GTC,TCT,TCA,TCA,TCG,
CAC,ACG,ACG,CAA,TGC,ACG,GTT,CCG,TCG,TCC,CAG,GTA,GAC,CAA,GAG
HCE11:
GTC,CAC,GCA,CTC,TGG,TTC,CTC,GAC,GCA,GCA,GCA,CAC,CCA,ATC,CTC,
GCA,GTC,GCA,AAC,TTC,CTC,GGT,CTC,ACC,TGG,CTC
HCE13:
ACC,GCA,ACC,TCC,CTC,ATC,GTC,TCC,GGT,GGT,ATC,ATC,GCA?GCA,TGG,
CTC,GCA,CTC,CAC,GTC,CAC,GCA,CTC,TGG,TTC,CTC
HCE15:
AGG,ATC,CAA,CAA,TGT,CCG,CAC,ACG,CAC,TCC,CAA,AAG,CAG,ACC,TCA,
CCG,CAA,CCT,CCC,TCA,TCG,TC
HCE2:
GGG,AAT,GCG,TCG,TGA,CCT,GGT,CTG,TGT,GGG,AGC,CAG,GTG,CCG,AAG,
ACG,AAG,AGT,TGG,ATG,GAT,GCG,AGG,ATG,GTA,GGG,AGT,GGC,CAG,AAG
HCE4:
CGA,AGT,GGA,AGC,AGG,TGA,GGA,GGG,AGA,CTG,GGT,CGG,AGA,TTC,TGG,
AGG,ATC,TTG,CGT,TGT,GTC,TGT,CTG,GGA,ATG,CGT,CGT,GAC,CTG,GTC
HCE6:
GGT,TCT,GGT,GGA,TGG,GAG,TCT,CCA,CCA,AGG,GAC,GGT,TGG,GTG,GAG,
GTG,GTG,TTC,GTG,GTG,GTA,GCC,ACC,GAA,GTG,GAA,GCA,GGT,GAG,GAG
HCE8:
AT,TCG,ACG,TCG,CCT,GCG,AGT,TTG,AGG,AGG,TCG,AAG,TTG,AGG,AGT,
TGT,GCG,GTG,TCG,CCT,TTG,GTT,CTG,GTG,GAT,GGG,AGT,CTC
HCE10:
GCG,ATG,AGA,CCG,TTT,GCG,AGA,CCT,GCA,CCT,GCG,AGG,AGG,ACG,TCG,
TGG,GTC,ATT,GGG,CCT,GGG,TTG,GAT,TCG,ACG,TCG,CCT,GCG,AGT,TTG
HCE12:
CGG,ATG,GAC,CTG,CTG,CGT,GGT,CGA,GGA,GGA,GGA,CTC,TGA,GGT,CTG,
GTC,TTG,CTG,CTC,TGA,GTG,CGA,GTG,CGA,TGA,GAC,CGT,TTG,CGA,GAC
HCE14:
GAG,TGG,CTT,GAG,TCT,TGC,GAG,CCA,GTG,TGG,GGA,GAG,GTC,TGG,GTC,
GTG,GCA,GGA,CCA,GGT,GTG,ACC,TTC,GGA,TGG,ACC,TGC,TGC,GTG,GTC
HCE16:
GTT,GCG,AGT,CTT,CTT,GCG,TGT,CTT,GGG,AAT,CTG,ACT,TCT,TGG,TCT,
GGC,CAG,TTT,GCT,CTT,CTG,AGT,GGC,TTG,AGT,CTT,GCG,AGC
Second section begins to termination codon TAA from 1008 ATG of gene, designs 14 primers altogether.The nucleotide sequence of primer is:
HCF1:
CGA,CCT,CGA,CGA,CGA,CGC,ACT,CGC,AGC,AGC,ATC,CCA,AGA,CTA,CGC,
AAG,ACA,ACA,AGG,CTG,GAC,CGG,TGC,AGA,AGT,CAG,AAG,AGA,AAG,AGG
HCF3:
TTC,ATC,TAC,CTC,CTC,CCA,TTC,TCC,AGA,ACC,AGA,ATC,CTC,ATC,GAA,
GAC,ACC,AGA,TAC,TCC,GAC,GGC,GGC,GAC,CTC,GAC,GAC,GAC,GCA,CTC
HCF5:
AGA,CCA,CAC,GGT,GTC,CCA,AGA,CCA,GTC,ATC,ATG,GAC,GGC,ACC,GTC,
ACC,CAA,AGA,GAC,GGC,TAC,GGC,TTC,ATC,TAC,CTC,CTC,CCA,TTC,TCC
HCF7:
GCC,CAC,ACC,CAT,CCA,GAC,ACC,TCA,CCC,TCG,GCT,TCC,ACA,AGT,TCC,
TCG,GTG,TCG,AAA,TCG,AAA,CCG,ACA,GAC,CAC,ACG,GTG,TCC,CAA,GAC
HCF9:
ACG,CAC,AAG,GTG,CAA,CCC,TCT,CCT,GCG,GTA,CTA,GAA,TCG,AAG,CAG,
GCT,CCG,TCC,TCG,ACG,GCA,GAG,GCC,CAC,ACC,CAT,CCA,GAC,ACC
HCF11:
AGC,ACT,CGC,AGA,CGC,AGT,CGT,CAG,ATC,CGG,TGC,AGA,AAT,CAG,ATG,
GGA,CTC,CGA,CAT,CGC,ACT,CCT,CGA,CGC,ACA,AGG,TGC,AAC,CCT,CTC
HCF13:
CAA,GAC,ACG,CAA,GAA,GAC,TCG,CAA,CCG,GCT,ACG,GCT,CCC,TCG,ACG,
GTG,CAG,CAC,TCG,CAG,ACG,CAG,TCG,TC
HCF2:
GAC,TGG,ACC,TTC,TGC,GTG,GTC,TGC,CCA,GAA,ACC,TGC,TGC,GTC,GTG,
TGC,GAG,TGC,GAT,TGG,GAG,GAT,GCC,TCT,TTC,TCT,TCT,GAC,TTC,TGC
HCF4:
GAC,TTG,TGC,TGC,GTA,TGG,GAG,GGA,GTA,GCC,GGT,GAC,TGG,GTG,GAA,
GAA,GCC,TGC,TCT,GAG,ACC,GAC,TGG,GAC,TGG,ACC,TTC,TGC,GTG,GTC
HCF6:
TAG,TCT,CTG,ATT,GCA,CCT,CTG,AGT,GCG,TCG,GTG,CCT,GGT,GGA,CCG,
GAG,AGA,CCT,GCG,ACG,ACG,TCT,GCG,ACT,TGT,GCT,GCG,TAT,GGG,AGG
HCF8:
CA,GCC,TCT,GAA,GAG,CAT,TCT,GTT,GAG,GAG,TCT,GAG,GAA,TCT,GTC,
TCT,TCT,TGC,TCT,GTC,GAT,TGC,GTA,GTC,TCT,GAT,TGC,ACC,TCT,GAG
HCF10:
T,TCG,ATG,AGA,CCT,TGT,GGC,ATT,CTG,TAG,AGT,CTT,TGG,AGG,AGG,GTG,TAT,CTT,CTG,TCT,GGT,GCG,CAG,CCT,CTG,AAG,AGC,ATT,CTG,TTG
HCF12:
GGA,TTG,GTG,GCT,TGC,CGG,TGA,CGA,TTC,TGA,GTT,GGT,CTG,CGA,CGG,
AGA,GTC,TAC,CTG,CGT,AGA,ATC,TTT,CGA,TGA,GAC,CGT,GTG,GCA,TTC
HCF14:
TTG,AGC,TCT,TAT,GCG,TTT,TCC,TTG,AGG,AGT,GGT,CTT,TCT,GGG,AGG,
CAT,CTG,ATT,GCG,GTG,CCG,AGT,GGG,ATT,GGT,GGC,TTG,CCG,GTG,ACG
After two sections of genes are synthetic, the PCR product is mixed, carry out new round pcr amplification, two fragments are merged into an associating gene.The pcr amplification condition is 94 ℃, 30s; 62 ℃, 30s; 72 ℃, 2min 30s.Carry out 25-35 circulation altogether.Synthetic associating gene crtWcrtY total length is 1997bP.
The chemosynthesis of embodiment 2 crtIcrtZ genes
According to Fig. 3 and design oligonucleotides synthetic primer shown in Figure 4, primer length is 60-90bp, and overlap is 20-30bp between two primers, and the Tm value is 64-80 ℃.
Utilize high temperature-resisting DNA polymerase eXTaq (the Japanese TAKANA company) synthetic gene of high-fidelity, all primers are added laggard performing PCR amplification, middle primer consumption is 5-10ng, and both sides primer consumption is 100-200ng, and the pcr amplification condition is 94 ℃, 30s; 60-72 ℃, 30s; 72 ℃, 1-2min.Carry out 25-35 circulation altogether.
The crtIcrtZ gene divides two sections to synthesize:
First section begins to 1080 from the gene codon ATG, designs 16 primers altogether.The nucleotide sequence of primer is:
HCC1:
TTC,CTC,AAG,CTC,GGT,CAA,ATG,CTC,AAG,GCA,GCA,CCA,GCA,CTC,ATG,
AAA,CTC,GAA,GCA,TAC,AAC,TCC,GTC,CAC,GCA,AAG,GTC,GCA,ACC,TTC
HCC3:
AGA,AGA,TTC,AGA,GAC,TAC,GCA,GAG,GAG,GTC,TAC,CAG,GAG,GGC,TAC,
GTC,AAA,CTC,GGC,ACC,GTC,CCA,TTC,CTC,AAG,CTC,GGT,CAA,ATG,CTC
HCC5:
GTC,AAC,GAG,GCA,GAC,CAA,CTC,GAA,AGA,CAA,ATC,GCA,CAA,TTC,AAC,
CCA,GAC,GAC,CTC,GAA,GGT,TAC,AGA,AGA,TTC,AGA,GAC,TAC,GCA,GAG
HCC7:
ACG,TCA,CCC,TCA,TGC,CAG,TCT,CCC,CAT,TCT,ACA,GAC,TCA,TGT,GGC,
CAG,GTG,GCA,AGG,TCT,TCG,ACT,ACG,TCA,ACG,AGG,CAG,ACC,AAC,TCG
HCC9:
AAC,CGT,CAT,CAC,CGA,CCC,AGA,CGC,ACT,CAA,GGA,ACT,CTG,GGC,ACT,
CAC,CGG,TCA,AGA,CAT,GGC,AAG,AGA,CGT,CAC,CCT,CAT,GCC,AGT,CTC
HCC11:
GCA,AGA,GAC,AAG,CCA,GGC,GGT,AGA,GCA,TAC,GTC,TGG,CAC,GAC,CAA,
GGC,CAC,GTC,TTC,GAC,GCA,GGT,CCA,ACC,GTC,ATC,ACC,GAC,CCA,GAC
HCC13:
AGG,TTT,CGG,TGG,TCT,CGC,ACT,CGC,AAT,CAG,ACT,CCA,ATC,CGC,AGG,
CAT,CGC,AAC,CAC,CCT,CGT,CGA,GGC,AAG,AGA,CAA,GCC,AGG,CGG,TAG
HCC15:
AGG,ATC,CAT,GGA,CGC,ACA,CTC,CCC,AGC,AGC,AAA,GAC,CGC,AAT,CGT,
CAT,CGG,TGC,AGG,TTT,CGG,TGG,TCT,CGC,ACT,C
HCC2:
GAG,AAT,GGA,TTA,CCA,CCG,ACG,AGG,AGG,GTG,TGG,TAG,GAG,AAT,GCC,
TGT,CTG,AGG,TAT,GGG,TCC,TTG,ATG,AAG,GTT,GCG,ACC,TTT,GCG,TGG
HCC4:
ACC,CTT,TGC,GAA,CCA,GAC,ACC,ACC,TCT,TCT,TTC,GAG,TGC,GTG,GAT,
GAG,TGC,GTA,GAT,GGA,GGA,GGT,GGA,GAA,TGG,ATT,ACC,ACC,GAC,GAG
HCC6:
TGA,GCA,TCA,TTT,GAC,CAC,CTG,GTC,TCT,CGA,AGA,GTG,CGA,CCA,TAC,
CTG,CGA,CGA,GCT,GGT,TGG,TGC,CAC,CCT,TTG,CGA,ACC,AGA,CAC,CAC
HCC8:
TAC,CGT,CTG,CGA,GGG,TGA,CAC,CGG,TGG,TTC,TTG,CAC,CCT,CGG,TTT,
CGA,TTC,TTG,CGA,CCT,TTG,CGT,TGA,GCA,TCA,TTT,GAC,CAC,CTG,GTC
HCC10:
ACC,GAG,GAG,GTC,TCT,GTA,GTT,GTG,CAT,GAC,GTC,ACC,GTT,GGA,TGC,
GAC,CAT,GTC,TGC,TCT,GAG,GGA,TCT,ACC,GTC,TGC,GAG,GGT,GAC,ACC
HCC12:
ACG,AAG,AGG,GAC,ATG,GAC,CAT,CTC,TTT,CTG,TCG,AGG,GAC,TTT,GCT,
CTG,GAT,TGA,CCT,CTT,GCG,GTG,TGA,CCG,AGG,AGG,TCT,CTG,TAG,TTG
HCC14:
ATC,TTG,GAC,CGA,AGA,GGA,TGG,TGT,GGT,GTG,CGA,TGT,CCT,TTG,GTG,
CTT,CTC,TGA,GAC,CGA,AGT,GGA,GGA,CGA,AGA,GGG,ACA,TGG,ACC,ATC
HCC16:
GG,AGG,TAG,AGG,GAG,AAG,TCC,TCT,GCG,AGT,TTT,GGA,CCC,TTG,AAG,ATT,TCG,TTG,ACG,AGT,TCC,TTG,TAT,CTT,GGA,CCG,AAG,AGG,ATG,GTG
Second section from 1080 of genes to the TAA termination codon, design 16 primers altogether.The nucleotide sequence of primer is:
HCD1:
GCA,ACC,GCA,CAA,GTC,ATG,CTC,CAA,CTC,CTC,AAC,TTC,GAC,CTC,CTC,
AAA,CTC,GCA,GGC,GAC,GTC,GAA,TCC,AAC,CCA,GGC,CCA,ATG,ACC,AAC
HCD3:
ACT,TCT,ACC,TCG,TCG,GTG,CAG,GTA,CTC,ACC,CAG,GTG,CAG,GTA,TCC,
CAG,GTG,TCG,TCG,GTT,CCG,CAA,AGG,CAA,CCG,CAC,AAG,TCA,TGC,TCC,
HCD5:
CTC,CGT,CGA,ACC,AAT,CCT,CAC,CCA,ATC,CGC,ATG,GTT,CAG,ACC,ACA,
CAA,CAG,AGA,CAA,GAC,CAT,CAG,AAA,CTT,CTA,CCT,CGT,CGG,TGC,AGG
HCD7:
AGA,ACC,AGA,ATC,TTC,ACC,CCA,GCA,GAC,TTC,GCA,TCC,GAA,CTC,AAC,
GCA,CAC,CAC,GGC,TCC,GCA,TTC,TCC,GTC,GAA,CCA,ATC,CTC,ACC
HCD9:
TAC,GCA,GAC,AGA,ATC,CTC,GCA,TTC,CTC,GAA,GAA,AGA,CTC,ATC,CCA,
AAC,CTC,AGA,GCA,AAC,CTC,ACC,AGA,ACC,AGA,ATC,TTC,ACC,CCA,GCA
HCD11:
GCA,CCA,GTC,CCA,CAC,CTC,TCC,AGA,GCA,GAA,ATC,GAC,TGG,GCA,GTC,
GAA,GGC,CCA,AGA,TAC,GCA,GAC,AGA,ATC,CTC,GCA,TTC
HCD13:
ATG,CAC,CAC,CGA,CCC,AGA,CAT,GGC,ACC,ACC,AGG,CAT,GTC,CAC,CCA,
CTA,CGT,CCT,CGC,ACC,AGT,CCC,ACA,CCT,CTC,C
HCD15:53bp
CAG,AGG,ACT,TCT,CCC,TCT,ACC,TCC,ACT,CCC,CAT,GCA,CCA,CCG,ACC,
CAG,ACA,TG
HCD2:
ATG,ATC,CAT,CTG,TGG,ACG,GAG,TAT,GCG,GTG,AGT,TCC,ATG,ACG,AGG,
ACG,GTT,GCG,ACG,ACG,ATG,AGG,AAG,TTG,GTC,ATT,GGG,CCT,GGG,TTG
HCD4:
TTT,TTC,GAG,TGC,GTG,GTC,GTG,TTC,TTC,GTG,GTG,GGA,TTT,GTG,CCA,
GCC,CCA,GCC,GAG,TGG,ACC,GTG,CAT,GAT,CCA,TCT,GTG,GAC,GGA,GTA
HCD6:
CCA,GAT,CCA,ACC,GAC,GGT,GAA,GAG,GAC,GGT,TGC,GAT,GAC,TGC,GAA,
GAC,GAG,ACC,GTA,GAG,GTC,GTT,TTT,TTC,GAG,TGC,GTG,GTC,GTG,TTC
HCD8:
TCG,TGG,AGG,ACG,AAG,TAG,ATG,AGA,CCG,TAG,ACG,GTC,ATA,CCG,AGT,
GCG,ATC,CAC,CAG,AGG,ACT,GGT,GCC,CAG,ATC,CAA,CCG,ACG,GTG,AAG
HCD10:
GAG,TCT,TCT,TGC,GTA,GCC,CTT,TCT,TGG,GAT,GTA,TCT,GAA,TGG,CCA,
TCT,TTG,GTG,GAC,GAC,ACC,GTC,GTG,GAG,GAC,GAA,GTA,GAT,GAG
HCD12:
AGA,TGA,AGC,CGA,AGG,AGA,CGC,AGT,GGT,CTC,TGC,CTT,CGA,CTG,CGT,
GGT,GGA,GTC,TGT,GTG,CTT,GGT,AGA,GTC,TTC,TTG,CGT,AGC,CCT,TTC
HCD14:
G,ACG,CCG,GAG,?GTC,TTG,AGG,TCT,TCT,TTG,AGT,TTA,TCG,ACT,GGT,GG
T,GCG,TAG,ATG,?AAG,CCG,AAG,GAG,ACG,CAG
HCD16:
G,TTG,GTG,ACC,TTA,GGT,TCT,TTC,TTC,TGC,TTC,TGC,TCT,GAG,GAC,GCC,GGA,GGT,CTT,GAG,GTC
After two sections of genes are synthetic, the PCR product is mixed, carry out new round pcr amplification, two fragments are merged into an associating gene.The pcr amplification condition is 94 ℃, 30s; 62 ℃, 30s; 72 ℃, 2min 30s.Carry out 25-35 circulation altogether.Synthetic associating gene crtIcrtE total length is 2034bP.
The chemosynthesis of embodiment 3 crtBcrtE genes
According to Fig. 5 and design oligonucleotides synthetic primer shown in Figure 6, primer length is 60-90bp, and overlap is 20-30bp between two primers, and the Tm value is 64-80 ℃.
Utilize high temperature-resisting DNA polymerase eXTaq (the Japanese TAKANA company) synthetic gene of high-fidelity, all primers are added laggard performing PCR amplification, middle primer consumption is 5-10ng, and both sides primer consumption is 100-200ng, and the pcr amplification condition is 94 ℃, 30s; 60-72 ℃, 30s; 72 ℃, 1-2min.Carry out 25-35 circulation altogether.
The crtBcrtE gene divides two sections to synthesize:
First section begins to 936 from the gene codon ATG, designs 14 primers altogether.The nucleotide sequence of primer is:
HCA1:
TCC,TAC,CAC,GTC,GCA,GGC,ATC,CTC,GGT,GTC,ATG,ATG,GCC,AGA,GTC,
ATG,GGT,GTC,AGA,GAC,CAC,CCA,GTC,CTC,GAC,AGA,GCC,TGC,GAC,CTC
HCA3:
CTC,ATC,GAG,GGC,TTC,GCA,ATC,GAC,GTT,GAG,GCA,AGA,GAC,TAC,AGA,
ACC,CTC,GAC,GAC,GTC,CTC,GAA,TAC,TCC,TAC,CAC,GTC,GCA,GGC,ATC
HCA5:
CTC,CAC,CAT,TCG,CAG,CAC,TCA,GAG,CAG,TCG,CAA,GAA,GAC,ACG,ACT,
TCC,CAC,AGG,CAT,GGC,CAA,TGG,ACC,TCA,TCG,AGG,GCT,TCG,CAA,TCG
HCA7:
ACA,GGC,CAG,ACT,CGA,CGG,TCT,CAG,AGC,CGA,CAC,CCT,CGC,AGC,ACT,
CCA,GGG,TGA,CGG,TCC,AGT,CAC,TCC,ACC,ATT,CGC,AGC,ACT,CAG
HCA9:
TGC,AGA,CAC,GCA,GAC,GAC,GTC,ATC,GAC,GGT,CAG,GCA,CTC,GGC,TCC,
AGA,CCA,GAG,GCA,GTC,AAC,GAC,CCA,CAG,GCC,AGA,CTC,GAC,GGT,CTC
HCA11:
CCT,TCG,CCA,CCG,CAG,CCA,AAC,TCA,TGC,CAC,CAG,GCA,TCA,GAG,ACG,
ACA,CCG,TCA,TGC,TCT,ACG,CCT,GGT,GCA,GAC,ACG,CAG,ACG,ACG,TCA
HCA13:
AGG,ATC,CAA,CAA,TGT,CCG,ACC,TCG,TCC,TCA,CCT,CCA,CCG,AGG,CCA,
TCA,CCC,AGG,GCT,CCC,AAT,CCT,TCG,CCA,CCG,CAG,CCA,AAC
HCA2:
GTA,GCA,TCT,GCC,GAT,TCT,TGC,GTA,GTC,GAT,GAC,GTC,TCT,TGC,GAT,
GTG,GGT,GAG,CTG,GAA,GGC,GAG,ACC,GAG,GTC,GCA,GGC,TCT,GTC,GAG
HCA4:90bp
TAG,AGT,TCT,GGG,GAT,GGG,ACT,GGA,CCA,TCG,ACT,CTT,GCG,CCT,GCG,
TGG,TCG,AGC,CAG,TCG,CCT,GGG,AGG,TAG,CAT,CTG,CCG,ATT,CTT,GCG
HCA6:
GCG,AGA,CCG,ACT,CTT,GCG,GAT,GGG,TAG,TAT,GGC,TCT,GCT,GCG,TCG,
AGG,AGT,CTG,AGG,ATG,ACG,GTG,TAG,AGT,TCT,GGG,GAT,GGA,CTG,G
HCA8:
GGA,GAC,CGA,TTG,CTC,TGT,AGA,TTC,TGA,ATG,CTG,CTG,GGA,TGG,ACC,
ATG,CGC,ATC,TTG,GTG,GGA,GGT,CTG,CGA,GAC,CGA,CTC,TTG,CGG,ATG
HCA10:
CGA,TCT,TTG,CTG,CCT,TGG,AGG,TGG,AGA,TTC,TTT,GTC,TGT,ATG,CCT,
CTG,GAC,CAC,CCT,TTC,TGA,TTG,GGA,GAC,CGA,TTG,CTC,TGT,AGA,TTC
HCA12:
TGT,CTG,GAG,ACA,CCG,GAG,CCT,CTG,CAA,GCG,TGG,TCT,GCG,ACG,TCC,
CAA,CCA,CCG,ATG,CCG,AGG,AGA,CCG,ATC,TTT,GCT,GCC,TTG,GAG,GTG
HCA14:
GAG,GAG,GTC,GAA,GTT,GAG,GAG,TTG,TGC,GTG,GTG,TGG,TCT,GGT,CCA,
GAG,GTC,TTG,TCT,GGA,GAC,ACC,GGA,GCC,TC
Second section from 936 of genes to the TAA termination codon, design 14 primers altogether.The nucleotide sequence of primer is:
HCB1:
CGC,ACT,CAT,CAC,CGA,AGC,AAT,GGC,ACT,CCT,CGC,AGG,TGC,AAG,AGG,
TGC,ATC,CGG,TAC,TGT,CAG,AGC,ACA,ACT,CGT,CAG,AAT,CCT,CTC,CAG
HCB3:
GTC,TCA,GAA,GAG,GTC,AAC,CAG,CAA,CCC,ACG,TCG,CAC,ACG,GTG,AAT,
CCA,GAG,CAG,TCC,TCG,GTG,GCA,TCG,CAC,TCA,TCA,CCG,AAG,CAA,TGG
HCB5:
CGC,AGT,CGA,AAT,GGT,CCA,CGC,AGC,ATC,CCT,CAT,CTT,CGA,CGA,CCT,
CCC,ATG,TAT,GGA,CGA,CGC,AGG,TCT,CAG,AAG,AGG,TCA,ACC,AGC,AAC
HCB7:
GTA,TGC,TCA,TGC,TCC,TCG,CAG,CAG,AAG,CAT,CCG,GTG,GTG,TCT,GCG,
ACA,CCA,TCG,TCG,ATG,CAG,CCT,GCG,,CAG,TCG,AAA,TGG,TCC,ACG,CAG
HCB9:
CTT,CGG,TGC,AGT,CCT,CCA,ACC,ACT,CGG,TGC,AGC,AAT,GGC,AGC,ACT,
CTC,CTC,CGG,TAA,GAG,ATT,CAG,AGG,TAT,GCT,CAT,GCT,CCT,CGC,AGC
HCB11:
ATG,AGA,AGA,GAC,GTC,AAC,CCA,ATC,CAC,GCA,ACC,CTC,CTC,CAA,ACC,
AGA,ATC,GAA,GAA,ATC,GCA,CAA,GGC,TTC,GGT,GCA,GTC,CTC,CAA,CCA
HCB13:
CAC,AAC,TCC,TCA,ACT,TCG,ACC,TCC,TCA,AAC,TCG,CAG,GCG,ACG,TCG,
AAT,CCA,ACC,CAG,GCC,CAA,TGA,GAA,GAG,ACG,TCA,ACC,CAA,TC
HCB2:
TGC,ACC,GTT,CTT,TGC,TGC,GTG,GAG,GTC,GAG,GTC,TTG,ACC,TGC,GCA,
GAG,ACC,TTG,TGG,ACC,GAG,GGA,TCT,GGA,GAG,GAT,TCT,GAC,GAG,TTG
HCB4:
ACT,GCG,AGC,ATT,TCG,AGA,CCT,GCG,ATG,AAG,AGG,ACA,CCG,GTT,TTG,
AGG,TCT,TGT,TCT,TGT,TCG,ACA,CCT,GCA,CCG,TTC,TTT,GCT,GCG,TGG
HCB6:
A,CTC,TAC,CGA,GTT,GTC,TAC,CGA,AGT,CGA,TCA,TTT,GGG,TTT,GTT,C
TT,CTG,CGT,CGA,ACT,CTT,TGA,TGA,CTG,CGA,GCA,TTT,CGA,GAC,CTG
HCB8:
CCG,GTG,TCT,TTA,CCG,AGT,GCT,GCT,TGA,TCA,CCG,ACG,ACT,TCG,AGG,
AGG,TCG,TCG,TAG,GAT,TGG,AAG,ACT,CTA,CCG,AGT,TGT,CTA,CCG,AAG
HCB10:
GAC,CTT,TTG,GAG,GTC,GGA,GAC,TGC,GAG,GAG,ACC,TCT,TCT,TGG,ACC,
TGG,TGC,TGC,TGC,GTC,TCT,ACC,GGT,GTC,TTT,ACC,GAG,TGC,TGC,TTG
HCB12:
GTG,CTT,GGA,GTC,TCT,TGG,AAC,CGA,CCA,TAC,CTT,CGA,GTT,GTG,CTC,
TGG,ATG,CTT,CGT,ATT,GTC,TGG,AGA,CCT,TTT,GGA,GGT,CGG,AGA,CTG
HCB14:
TT,GAG,CTC,TTA,TGC,TCT,TGC,TGC,GTA,TGG,GAG,GAC,TCT,TTC,GAG,
GAG,TGC,TTC,GAT,TTC,TGG,TGC,TTG,GAG,TCT,CTT,GGA,ACC
After two sections of genes are synthetic, the PCR product is mixed, carry out new round pcr amplification, two fragments are merged into an associating gene.The pcr amplification condition is 94 ℃, 30s; 62 ℃, 30s; 72 ℃, 2min 30s.Carry out 25-35 circulation altogether.Synthetic associating gene crtBcrtE total length is 1848bP.
The Function Identification of embodiment 4 synthetic genes.
Utilize PCR method to add BamHI and SalI restriction enzyme site at the two ends of synthetic gene crtWcrtY, add SalI and HindIII restriction enzyme site at the two ends of synthetic gene crtIcrtZ, add EcoRI+SacI and KpnI restriction enzyme site at the two ends of synthetic gene crtBcrtE.The crtWcrtY gene is inserted the pBluescripsMCS carrier, and (three Room, biological center, academy of agricultural sciences, Shanghai make up, 1998), insert the crtIcrtZ gene again at SalI and HindIII restriction enzyme site afterwards, 4 placed in-line genes are cut the back with BamHI and KpnI enzyme insert the corresponding restriction enzyme site of pCAMBIA1301 carrier (available from U.S. CAMBIA company), cut the crtBcrtE gene with EcoRI and KpnI enzyme again, insert the corresponding restriction enzyme site of this carrier, constitute the placed in-line associating gene of 6 genes.
In order to verify the function of gene, with 6 gene constructed under prokaryotic promoter control, transformed into escherichia coli allows them at expression in escherichia coli.After cutting tandem gene with BamHI and SacI enzyme, (three Room, biological center, academy of agricultural sciences, Shanghai make up to insert pYP2001,1998) corresponding restriction enzyme site, make up the expression system of 6 tandem genes, chemical method transformed into escherichia coli DH5 α, intestinal bacteria are uniformly coated on the flat board that contains the kantlex substratum, cultivate after 12 hours for 37 ℃, observe the colour-change (Figure 10) of bacterium colony, the intestinal bacteria that red bacterium colony occurs show that gene has been transformed in the intestinal bacteria, and given expression to activated protein therein, make the intestinal bacteria synthesizing astaxanthin.
Claims (12)
1, by ridge ox base ridge ox base pyrophosphate synthetase gene (crtE) from secondary coccus; Phytoene synthase gene (crtB); Phytoene desaturase gene (crtI); Lycopene beta cyclase gene (crtY); β-Hu Luobusu '-hydroxylase gene (crtZ) and β-Hu Luobusu ketolase gene (crtW) is characterized in that becoming leading astaxanthin biological synthetic crtW crtY gene and crtI crtZ and crtB crtE associating gene by aforementioned six kinds of genetic modifications.
2, as follows according to described leading astaxanthin biological synthetic crtWcrtY gene nucleotide of claim 1 and aminoacid sequence:
ATGTCCGCACACGCACTCCCAAAAGCAGACCTCACCGCAACCTCCCTCATCGTCTCCGGTGGTATCATCGCA--?72
M S A H A L P K A D L T A T S L I V S G G I I A
GCATGGCTCGCACTCCACGTCCACGCACTCTGGTTCCTCGACGCAGCAGCACACCCAATCCTCGCAGTCGCA--144
A W L A L H V H A L W F L D A A A H P I L A V A
AACTTCCTCGGTCTCACCTGGCTCTCCGTCGGTCTCTTCATCATCGCACACGACGCAATGCACGGTTCCGTC--216
N F L G L T W L S V G L F I I A H D A M H G S V
GTCCCAGGTAGACCAAGAGCAAACGCAGCAATGGGTCAACTCGTCCTCTGGCTCTACGCAGGTTTCTCCTGG--288
V P G R P R A N A A M G Q L V L W L Y A G F S W
AGAAAGATGATCGTCAAGCACATGGCACACCACAGACACGCAGGTACTGACGACGACCCAGACTTCGACCAC--360
R K M I V K H M A H H R H A G T D D D P D F D H
GGTGGTCCAGTCAGATGGTACGCAAGATTCATCGGTACTTACTTCGGTTGGAGAGAAGGTCTCCTCCTCCCA--432
G G P V R W Y A R F I G T Y F G W R E G L L L P
GTCATCGTCACCGTCTACGCACTCATCCTCGGTGACAGATGGATGTACGTCGTCTTCTGGCCACTCCCATCC--504
V I V T V Y A L I L G D R W M Y V V F W P L P S
ATCCTCGCATCCATCCAACTCTTCGTCTTCGGCACCTGGCTCCCACACAGACCAGGTCACGACGCATTCCCA--576
I L A S I Q L F V F G T W L P H R P G H D A F P
GACAGACACAACGCAAGATCCTCCAGAATCTCCGACCCAGTCTCCCTCCTCACCTGCTTCCACTTCGGTGGC--648
D R H N A R S S R I S D P V S L L T C F H F G G
TACCACCACGAACACCACCTCCACCCAACCGTCCCTTGGTGGAGACTCCCATCCACCAGAACCAAAGGCGAC--720
Y H H E H H L H P T V P W W R L P S T R T K G D
ACCGCACAACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGAATCCAACCCAGGCCCAATGACC--792
T A Q L L N F D L L K L A G D V E S N P G P M T
CACGACGTCCTCCTCGCAGGTGCAGGTCTCGCAAACGGTCTCATCGCACTCGCACTCAGAGCAGCAAGACCA--864
H D V L L A G A G L A N G L I A L A L R A A R P
GACCTCAGAGTCCTCCTCCTCGACCACGCAGCAGGTCCATCCGAAGGTCACACCTGGTCCTGCCACGACCCA--936
D L R V L L L D H A A G P S E G H T W S C H D P
GACCTCTCCCCACACTGGCTCGCAAGACTCAAGCCACTCAGAAGAGCAAACTGGCCAGACCAAGAAGTCAGA-1008
D L S P H W L A R L K P L R R A N W P D Q E V R
TTCCCAAGACACGCAAGAAGACTCGCAACCGGCTACGGCTCCCTCGACGGTGCAGCACTCGCAGACGCAGTC-1080
F P R H A R R L A T G Y G S L D G A A L A D A V
GTCAGATCCGGTGCAGAAATCAGATGGGACTCCGACATCGCACTCCTCGACGCACAAGGTGCAACCCTCTCC-1152
V R S G A E I R W D S D I A L L D A Q G A T L S
TGCGGTACTAGAATCGAAGCAGGCTCCGTCCTCGACGGCAGAGGCCCACACCCATCCAGACACCTCACCCTC-1224
C G T R I E A G S V L D G R G P H P S R H L T L
GGCTTCCACAAGTTCCTCGGTGTCGAAATCGAAACCGACAGACCACACGGTGTCCCAAGACCAGTCATCATG-1296
G F H K F L G V E I E T D R P H G V P R P V I M
GACGGCACCGTCACCCAAAGAGACGGCTACGGCTTCATCTACCTCCTCCCATTCTCCAGAACCAGAATCCTC-1368
D G T V T Q R D G Y G F I Y L L P F S R T R I L
ATCGAAGACACCAGATACTCCGACGGCGGCGACCTCGACGACGACGCACTCGCAGCAGCATCCCAAGACTAC-1440
I E D T R Y S D G G D L D D D A L A A A S Q D Y
GCAAGACAACAAGGCTGGACCGGTGCAGAAGTCAGAAGAGAAAGAGGCATCCTCCCAATCGCACTCGCACAC-1512
A R Q Q G W T G A E V R R E R G I L P I A L A H
GACGCAGCAGGTTTCTGGGCAGACCACGCAGAAGGTCCAGTCCCAGTCGGTCTCAGAGCAGGCTTCTTCCAC-1584
D A A G F W A D H A E G P V P V G L R A G F F H
CCAGTCACCGGCTACTCCCTCCCATACGCAGCACAAGTCGCAGACGTCGTCGCAGGTCTCTCCGGTCCACCA-1556
P V T G Y S L P Y A A Q V A D V V A G L S G P P
GGCACCGACGCACTCAGAGGTGCAATCAGAGACTACGCAATCGACAGAGCAAGAAGAGACAGATTCCTCAGA-1728
G T D A L R G A I R D Y A I D R A R R D R F L R
CTCCTCAACAGAATGCTCTTCAGAGGCTGCGCACCAGACAGAAGATACACCCTCCTCCAAAGACTCTACAGA-1800
L L N R M L F R G C A P D R R Y T L L Q R L Y R
ATGCCACACGGTCTCATCGAAAGATTCTACGCAGGTAGACTCTCCGTCGCAGACCAACTCAGAATCGTCACC-1872
M P H G L I E R F Y A G R L S V A D Q L R I V T
GGCAAGCCACCAATCCCACTCGGCACCGCAATCAGATGCCTCCCAGAAAGACCACTCCTCAAGGAAAACGCA-1994
G K P P I P L G T A I R C L P E R P L L K E N A
3, as follows according to described leading astaxanthin biological synthetic crtIcrtZ gene nucleotide of claim 1 and aminoacid sequence:
ATGAACGCACACTCCCCAGCAGCAAAGACCGCAATCGTCATCGGTGCAGGTTTCGGTGGTCTCGCACTCGCA--?72
M N A H S P A A K T A I V I G A G F G G L A L A
ATCAGACTCCAATCCGCAGGCATCGCAACCACCCTCGTCGAGGCAAGAGACAAGCCAGGCGGTAGAGCATAC--144
I R L Q S A G I A T T L V E A R D K P G G R A Y
GTCTGGCACGACCAAGGCCACGTCTTCGACGCAGGTCCAACCGTCATCACCGACCCAGACGCACTCAAGGAA--216
V W H D Q G H V F D A G P T V I T D P D A L K E
CTCTGGGCACTCACCGGTCAAGACATGGCAAGAGACGTCACCCTCATGCCAGTCTCCCCATTCTACAGACTC--288
L W A L T G Q D M A R D V T L M P V S P F Y R L
ATGTGGCCAGGTGGCAAGGTCTTCGACTACGTCAACGAGGCAGACCAACTCGAAAGACAAATCGCACAATTC--360
M W P G G K V F D Y V N E A D Q L E R Q I A Q FAACCCAGACGACCTCGAAGGTTACAGAAGATTCAGAGACTACGCAGAGGAGGTCTACCAGGAGGGCTACGTC--432?N P D D L E G Y R R F R D Y A E E V Y Q E G Y VAAACTCGGCACCGTCCCATTCCTCAAGCTCGGTCAAATGCTCAAGGCAGCACCAGCACTCATGAAACTCGAA--504?K L G T V P F L K L G Q M L K A A P A L M K L EGCATACAACTCCGTCCACGCAAAGGTCGCAACCTTCATCAAGGACCCATACCTCAGACAGGCATTCTCCTAC--576?A Y N S V H A K V A T F I K D P Y L R Q A F S YCACACCCTCCTCGTCGGTGGTAATCCATTCTCCACCTCCTCCATCTACGCACTCATCCACGCACTCGAAAGA--648?H T L L V G G N P F S T S S I Y A L I H A L E RAGAGGTGGTGTCTGGTTCGCAAAGGGTGGCACCAACCAGCTCGTCGCAGGTATGGTCGCACTCTTCGAGAGA--720?R G G V W F A K G G T N Q L V A G M V A L F E RCCAGGTGGTCAAATGATGCTCAACGCAAAGGTCGCAAGAATCGAAACCGAGGGTGCAAGAACCACCGGTGTC--792?P G G Q M M L N A K V A R I E T E G A R T T G VACCCTCGCAGACGGTAGATCCCTCAGAGCAGACATGGTCGCATCCAACGGTGACGTCATGCACAACTACAGA--864?T L A D G R S L R A D M V A S N G D V M H N Y RGACCTCCTCGGTCACACCGCAAGAGGTCAATCCAGAGCAAAGTCCCTCGACAGAAAGAGATGGTCCATGTCC--936?D L L G H T A R G Q S R A K S L D R K R W S M SCTCTTCGTCCTCCACTTCGGTCTCAGAGAAGCACCAAAGGACATCGCACACCACACCATCCTCTTCGGTCCA-1008?L F V L H F G L R E A P K D I A H H T I L F G PAGATACAAGGAACTCGTCAACGAAATCTTCAAGGGTCCAAAACTCGCAGAGGACTTCTCCCTCTACCTCCAC-1080?R Y K E L V N E I F K G P K L A E D F S L Y L HTCCCCATGCACCACCGACCCAGACATGGCACCACCAGGCATGTCCACCCACTACGTCCTCGCACCAGTCCCA-1152?S P C T T D P D M A P P G M S T H Y V L A P V PCACCTCTCCAGAGCAGAAATCGACTGGGCAGTCGAAGGCCCAAGATACGCAGACAGAATCCTCGCATTCCTC-1224?H L S R A E I D W A V E G P R Y A D R I L A F LGAAGAAAGACTCATCCCAAACCTCAGAGCAAACCTCACCAGAACCAGAATCTTCACCCCAGCAGACTTCGCA-1296?E E R L I P N L R A N L T R T R I F T P A D F ATCCGAACTCAACGCACACCACGGCTCCGCATTCTCCGTCGAACCAATCCTCACCCAATCCGCATGGTTCAGA-1368?S E L N A H H G S A F S V E P I L T Q S A W F RCCACACAACAGAGACAAGACCATCAGAAACTTCTACCTCGTCGGTGCAGGTACTCACCCAGGTGCAGGTATC-1440?P H N R D K T I R N F Y L V G A G T H P G A G ICCAGGTGTCGTCGGTTCCGCAAAGGCAACCGCACAAGTCATGCTCCAACTCCTCAACTTCGACCTCCTCAAA-1512?P G V V G S A K A T A Q V M L Q L L N F D L L KCTCGCAGGCGACGTCGAATCCAACCCAGGCCCAATGACCAACTTCCTCATCGTCGTCGCAACCGTCCTCGTC-1584?L A G D V E S N P G P M T N F L I V V A T V L VATGGAACTCACCGCATACTCCGTCCACAGATGGATCATGCACGGTCCACTCGGCTGGGGCTGGCACAAATCC-1656?M E L T A Y S V H R W I M H G P L G W G W H K SCACCACGAAGAACACGACCACGCACTCGAAAAAAACGACCTCTACGGTCTCGTCTTCGCAGTCATCGCAACC-1728?H H E E H D H A L E K N D L Y G L V F A V I A TGTCCTCTTCACCGTCGGTTGGATCTGGGCACCAGTCCTCTGGTGGATCGCACTCGGTATGACCGTCTACGGT-1800?V L F T V G W I W A P V L W W I A L G M T V Y GCTCATCTACTTCGTCCTCCACGACGGTGTCGTCCACCAAAGATGGCCATTCAGATACATCCCAAGAAAGGGC-1872?L I Y F V L H D G V V H Q R W P F R Y I P R K GTACGCAAGAAGACTCTACCAAGCACACAGACTCCACCACGCAGTCGAAGGCAGAGACCACTGCGTCTCCTTC-1944?Y A R R L Y Q A H R L H H A V E G R D H C V S FGGCTTCATCTACGCACCACCAGTCGATAAACTCAAAGAAGACCTCAAGACCTCCGGCGTCCTCAGAGCAGAA-2016
G F I Y A P P V D K L K E D L K T S G V L R A E
GCAGAAGAAAGAACCTAA-2034
A E E R T
4, as follows according to described leading astaxanthin biological synthetic crtBcrtE gene nucleotide of claim 1 and aminoacid sequence:
ATGTCCGACCTCGTCCTCACCTCCACCGAGGCCATCACCCAGGGCTCCCAATCCTTCGCCACCGCAGCCAAA--?72
M S D L V L T S T E A I T Q G S Q S F A T A A K
CTCATGCCACCAGGCATCAGAGACGACACCGTCATGCTCTACGCCTGGTGCAGACACGCAGACGACGTCATC--144
L M P P G I R D D T V M L Y A W C R H A D D V I
GACGGTCAGGCACTCGGCTCCAGACCAGAGGCAGTCAACGACCCACAGGCCAGACTCGACGGTCTCAGAGCC--216
D G Q A L G S R P E A V N D P Q A R L D G L R A
GACACCCTCGCAGCACTCCAGGGTGACGGTCCAGTCACTCCACCATTCGCAGCACTCAGAGCAGTCGCAAGA--288
D T L A A L Q G D G P V T P P F A A L R A V A R
AGACACGACTTCCCACAGGCATGGCCAATGGACCTCATCGAGGGCTTCGCAATCGACGTTGAGGCAAGAGAC--360
R H D F P Q A W P M D L I E G F A I D V E A R D
TACAGAACCCTCGACGACGTCCTCGAATACTCCTACCACGTCGCAGGCATCCTCGGTGTCATGATGGCCAGA--432
Y R T L D D V L E Y S Y H V A G I L G V M M A R
GTCATGGGTGTCAGAGACCACCCAGTCCTCGACAGAGCCTGCGACCTCGGTCTCGCCTTCCAGCTCACCCAC--504
V M G V R D H P V L D R A C D L G L A F Q L T H
ATCGCAAGAGACGTCATCGACTACGCAAGAATCGGCAGATGCTACCTCCCAGGCGACTGGCTCGACCACGCA--576
I A R D V I D Y A R I G R C Y L P G D W L D H A
GGCGCAAGAGTCGATGGTCCAGTCCCATCCCCAGAACTCTACACCGTCATCCTCAGACTCCTCGACGCAGCA--648
G A R V D G P V P S P E L Y T V I L R L L D A A
GAGCCATACTACCCATCCGCAAGAGTCGGTCTCGCAGACCTCCCACCAAGATGCGCATGGTCCATCCCAGCA--720
E P Y Y P S A R V G L A D L P P R C A W S I P A
GCATTCAGAATCTACAGAGCAATCGGTCTCCCAATCAGAAAGGGTGGTCCAGAGGCATACAGACAAAGAATC--792
A F R I Y R A I G L P I R K G G P E A Y R Q R I
TCCACCTCCAAGGCAGCAAAGATCGGTCTCCTCGGCATCGGTGGTTGGGACGTCGCAGACCACGCTTGCAGA--864
S T S K A A K I G L L G I G G W D V A D H A C R
GGCTCCGGTGTCTCCAGACAAGACCTCTGGACCAGACCACACCACGCACAACTCCTCAACTTCGACCTCCTC--936
G S G V S R Q D L W T R P H H A Q L L N F D L L
AAACTCGCAGGCGACGTCGAATCCAACCCAGGCCCAATGAGAAGAGACGTCAACCCAATCCACGCAACCCTC--1008
K L A G D V E S N P G P M R R D V N P I H A T L
CTCCAAACCAGAATCGAAGAAATCGCACAAGGCTTCGGTGCAGTCCTCCAACCACTCGGTGCAGCAATGGCA--1080
L Q T R I E E I A Q G F G A V L Q P L G A A M A
GCACTCTCCTCCGGTAAGAGATTCAGAGGTATGCTCATGCTCCTCGCAGCAGAAGCATCCGGTGGTGTCTGC--1152
A L S S G K R F R G M L M L L A A E A S G G V C
GACACCATCGTCGATGCAGCCTGCGCAGTCGAAATGGTCCACGCAGCATCCCTCATCTTCGACGACCTCCCA--1224
D T I V D A A C A V E M V H A A S L I F D D L P
TGTATGGACGACGCAGGTCTCAGAAGAGGTCAACCAGCAACCCACGTCGCACACGGTGAATCCAGAGCAGTC--1296
C M D D A G L R R G Q P A T H V A H G E S R A V
CTCGGTGGCATCGCACTCATCACCGAAGCAATGGCACTCCTCGCAGGTGCAAGAGGTGCATCCGGTACTGTC--1368
L G G I A L I T E A M A L L A G A R G A S G T V
AGAGCACAACTCGTCAGAATCCTCTCCAGATCCCTCGGTCCACAAGGTCTCTGCGCAGGTCAAGACCTCGAC--1440
R A Q L V R I L S R S L G P Q G L C A G Q D L D
CTCCACGCAGCAAAGAACGGTGCAGGTGTCGAACAAGAACAAGACCTCAAAACCGGTGTCCTCTTCATCGCA--1512
L H A A K N G A G V E Q E Q D L K T G V L F I A
GGTCTCGAAATGCTCGCAGTCATCAAAGAGTTCGACGCAGAAGAACAAACCCAAATGATCGACTTCGGTAGA--1584
G L E M L A V I K E F D A E E Q T Q M I D F G R
CAACTCGGTAGAGTCTTCCAATCCTACGACGACCTCCTCGAAGTCGTCGGTGATCAAGCAGCACTCGGTAAA--1656
Q L G R V F Q S Y D D L L E V V G D Q A A L G K
GACACCGGTAGAGACGCAGCAGCACCAGGTCCAAGAAGAGGTCTCCTCGCAGTCTCCGACCTCCAAAAGGTC--1728
D T G R D A A A P G P R R G L L A V S D L Q K V
TCCAGACAATACGAAGCATCCAGAGCACAACTCGAAGGTATGGTCGGTTCCAAGAGACTCCAAGCACCAGAA--1800
S R Q Y E A S R A Q L E G M V G S K R L Q A P E
ATCGAAGCACTCCTCGAAAGAGTCCTCCCATACGCAGCAAGAGCATAA--1848
I E A L L E R V L P Y A A R A
5, the synthetic method of leading astaxanthin biological synthetic crtWcrtY, crtIcrtZ and crtBcrtE gene, it is characterized in that adopting the high temperature resistant polysaccharase PCR of high-fidelity to increase, nucleotide sequence is cloned and surveyed to gene in intestinal bacteria, insert automatically cutting sequence different positions inserts cutting sequence automatically in the junction of crtWcrtY, crtIcrtZ and crtBcrtE gene
CAACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGA
ATCCAACCCAGGCCCA synthesizes.
6, according to the synthetic method of the described leading astaxanthin biological synthetic gene of claim 5, it is characterized in that synthetic crtWcrtY gene, totally 1997 nucleotide bases are right from codon ATG to termination codon TAA, insert cutting sequence C AACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGAATCCAACCCAGGC CCA automatically in 726~786 positions of gene.
7, according to the synthetic method of the described leading astaxanthin biological synthetic gene of claim 5, it is characterized in that synthetic crtIcrtZ gene, totally 2034 nucleotide bases are right from codon ATG to termination codon TAA, insert cutting sequence automatically in 1485~1545 positions of gene
CAACTCCTCAACTTCGACCTCCTCAAACTCGCA
GGCGACGTCGAATCCAACCCAGGCCCA。
8, according to the synthetic method of the described leading astaxanthin biological synthetic gene of claim 5, it is characterized in that synthetic crtBcrtE gene, totally 1848 nucleotide bases are right from codon ATG to termination codon TAA, insert one in 912~972 positions of gene and cut sequence C AACTCCTCAACTTCGACCTCCTCAAACTCGCAGGCGACGTCGAATCCAACCCAGGC CCA automatically.
9, according to the synthetic method of the described leading astaxanthin biological synthetic gene of claim 5, it is characterized in that crtWcrtY, crtIcrtZ, the two ends of crtBcrtE add BamHI and SalI restriction enzyme site respectively; SalI and HindIII restriction enzyme site; EcoRI+SacI and KpnI restriction enzyme site, the crtWcrtY gene is inserted the pBluescripsMCS carrier, SalI and HindIII restriction enzyme site are inserted the crtIcrtZ gene again, again four placed in-line genes are cut the back with BamHI and KpnI enzyme and insert the corresponding restriction enzyme site of pCAMBIA1301 carrier, cut the crtBcrtE gene with EcoRI and KpnI enzyme again, insert the corresponding restriction enzyme site of this carrier, constitute the placed in-line associating gene of 6 genes.
10, use 6 genes series connection of employing according to the described leading astaxanthin biological synthetic gene function of claim 1, be structured in prokaryotic promoter control down, transformed into escherichia coli, make them at expression in escherichia coli, after cutting tandem gene with BamHI and SacI enzyme, insert the corresponding restriction enzyme site of pYP2001, be built into the expression system of six tandem genes, given expression to activated protein and made the intestinal bacteria synthesizing astaxanthin.
11, according to the described leading astaxanthin biological synthetic gene of claim 1, it is characterized in that by crtW and crtY; CrtI and crtZ; CrtB and crtE are composed in series 3 associating genes, according to the preference password synthesizing ribonucleotide of plant.
12, leading according to claim 1 astaxanthin biological synthetic gene can and utilize in the plant production astaxanthin in the plant modification quality and use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01105878 CN1380415A (en) | 2001-04-06 | 2001-04-06 | Synthesis of related gene for producing carotenoid in transgenic plant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01105878 CN1380415A (en) | 2001-04-06 | 2001-04-06 | Synthesis of related gene for producing carotenoid in transgenic plant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1380415A true CN1380415A (en) | 2002-11-20 |
Family
ID=4654942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01105878 Pending CN1380415A (en) | 2001-04-06 | 2001-04-06 | Synthesis of related gene for producing carotenoid in transgenic plant |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1380415A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7074604B1 (en) | 2004-12-29 | 2006-07-11 | E. I. Du Pont De Nemours And Company | Bioproduction of astaxanthin using mutant carotenoid ketolase and carotenoid hydroxylase genes |
| US7091031B2 (en) | 2004-08-16 | 2006-08-15 | E. I. Du Pont De Nemours And Company | Carotenoid hydroxylase enzymes |
| US7425625B2 (en) | 2004-06-08 | 2008-09-16 | E.I. Du Pont De Nemours And Company | Carotenoid ketolase genes with improved ketocarotenoid yield |
| CN102061289A (en) * | 2009-11-13 | 2011-05-18 | 韩国生命工学研究院 | Beta-carotene hydroxylase gene increasing beta-carotene content of plants and use of beta-carotene hydroxylase gene |
| CN102286504A (en) * | 2011-07-01 | 2011-12-21 | 浙江大学 | Lycopene cyclase gene in sphingomonas sp. and use thereof |
| CN101768593B (en) * | 2009-01-06 | 2013-01-30 | 上海市农业科学院 | Paracoccus astaxanthin synthesis operon and its expression vector and application |
| CN107418968A (en) * | 2017-06-02 | 2017-12-01 | 湖北大学 | A kind of method that astaxanthin is efficiently produced using Nicotiana tabacum plastid |
| CN109593120A (en) * | 2019-01-15 | 2019-04-09 | 华中农业大学 | A kind of preparation method of orange carotenoids fibroin |
| CN111206042A (en) * | 2020-02-25 | 2020-05-29 | 中国科学院昆明植物研究所 | Fusion gene for expressing ketocarotenoid, recombinant vector and application thereof |
| CN113699052A (en) * | 2020-05-20 | 2021-11-26 | 万华化学(四川)有限公司 | Recombinant saccharomyces cerevisiae for producing astaxanthin and application thereof |
-
2001
- 2001-04-06 CN CN 01105878 patent/CN1380415A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425625B2 (en) | 2004-06-08 | 2008-09-16 | E.I. Du Pont De Nemours And Company | Carotenoid ketolase genes with improved ketocarotenoid yield |
| US7091031B2 (en) | 2004-08-16 | 2006-08-15 | E. I. Du Pont De Nemours And Company | Carotenoid hydroxylase enzymes |
| US7074604B1 (en) | 2004-12-29 | 2006-07-11 | E. I. Du Pont De Nemours And Company | Bioproduction of astaxanthin using mutant carotenoid ketolase and carotenoid hydroxylase genes |
| CN101768593B (en) * | 2009-01-06 | 2013-01-30 | 上海市农业科学院 | Paracoccus astaxanthin synthesis operon and its expression vector and application |
| CN102061289A (en) * | 2009-11-13 | 2011-05-18 | 韩国生命工学研究院 | Beta-carotene hydroxylase gene increasing beta-carotene content of plants and use of beta-carotene hydroxylase gene |
| CN102061289B (en) * | 2009-11-13 | 2013-01-23 | 韩国生命工学研究院 | Beta-carotene hydroxylase gene increasing beta-carotene content of plants and use of beta-carotene hydroxylase gene |
| CN102286504A (en) * | 2011-07-01 | 2011-12-21 | 浙江大学 | Lycopene cyclase gene in sphingomonas sp. and use thereof |
| CN107418968A (en) * | 2017-06-02 | 2017-12-01 | 湖北大学 | A kind of method that astaxanthin is efficiently produced using Nicotiana tabacum plastid |
| CN109593120A (en) * | 2019-01-15 | 2019-04-09 | 华中农业大学 | A kind of preparation method of orange carotenoids fibroin |
| CN111206042A (en) * | 2020-02-25 | 2020-05-29 | 中国科学院昆明植物研究所 | Fusion gene for expressing ketocarotenoid, recombinant vector and application thereof |
| CN113699052A (en) * | 2020-05-20 | 2021-11-26 | 万华化学(四川)有限公司 | Recombinant saccharomyces cerevisiae for producing astaxanthin and application thereof |
| CN113699052B (en) * | 2020-05-20 | 2023-08-11 | 万华化学(四川)有限公司 | A recombinant Saccharomyces cerevisiae producing astaxanthin and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100347291C (en) | Microorganisms and processes for fermentative preparation of L-cysteine, L-cystine, N-acetylserine or thiazolidine derivatives | |
| CN1247783C (en) | Fermentation method of producing L-amino acid | |
| CN101044243A (en) | Process for producing isoprenoids | |
| CN1146781A (en) | Riboflavin biosynthesis in fungi | |
| CN1968688A (en) | Expression of fatty acid desaturases in corn | |
| CN1656226A (en) | Methods for the production of unsaturated fatty acids | |
| CN1644696A (en) | Genes coding for flavone synthases | |
| CN1308457C (en) | Method for fermentatively producing s-adenosylmethionine | |
| CN101052719A (en) | Method for stabilizing and blueing anthocyanin pigments using a gene encoding anthocyanin 3'-position aromatic acyltransferase | |
| CN1541264A (en) | lipoxygenase | |
| CN1380415A (en) | Synthesis of related gene for producing carotenoid in transgenic plant | |
| CN1818067A (en) | Zoophobous fusion protein and use thereof | |
| CN1558953A (en) | Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carRP) and phytoene dehydrogenase (carB) | |
| CN101041837A (en) | Preparation method of new natural abscisic acid | |
| CN1536072A (en) | Inosine producing bacterium belonging to the genus bacillus and method for producing inosine | |
| CN1592780A (en) | Gamma-glutamylcysteine-producing yeast | |
| CN1898383A (en) | Unsaturated fatty acid synthesis system enzyme genes and their utilization | |
| CN1661015A (en) | Glutathione synthetase-coding gene of candida utilis | |
| CN1774505A (en) | Candida utilis containing gamma-glutamylcysteine | |
| CN1198921C (en) | Raffinose synthase gene, preparation method of raffinose and transformed plant | |
| CN101061222A (en) | Genes encoding methylated catechin biosynthetic enzymes | |
| CN1629194A (en) | Super antigen fusion protein for cancer therapy and its producing method | |
| CN1844377A (en) | 9-cis epoxy carotinoid dioxygenase in Stylosanthes guianensis and genes encoding same and use thereof | |
| CN1599796A (en) | Genetic strain optimization for improving the production of riboflavin | |
| CN1190492C (en) | Cotton Na+/H+ reverse transport protein gene and its cloning method and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |